<?xml version="1.0" encoding="ISO-8859-1" standalone="no"?>
<COCHRANE_REVIEW DESCRIPTION="Corrected 'Characteristics of included/excluded studies' table footnotes from superscript; mark for publication" DOI="10.1002/14651858.CD008521.pub5" GROUP_ID="INFECTN" ID="777088223322086270" MERGED_FROM="" MODIFIED="2022-04-25 22:08:50 +0100" MODIFIED_BY="[Empty name]" REVIEW_NO="" REVMAN_SUB_VERSION="5.4.1" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.7">
<COVER_SHEET MODIFIED="2019-03-19 15:09:11 +0000" MODIFIED_BY="19988051606560128665111114094226">
<TITLE MODIFIED="2019-10-21 15:25:16 +0100" MODIFIED_BY="root">Vaccines for preventing rotavirus diarrhoea: vaccines in use</TITLE>
<CONTACT>
<PERSON ID="59249928586857976988110908155847" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Hanna</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Bergman</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>hbergman@cochrane.org</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Response</DEPARTMENT>
<ORGANISATION>Cochrane</ORGANISATION>
<ADDRESS_1>St Albans House</ADDRESS_1>
<ADDRESS_2>57-59 Haymarket</ADDRESS_2>
<CITY>London</CITY>
<ZIP>SW1Y 4QX</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847">
<PERSON ID="59249928586857976988110908155847" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Hanna</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Bergman</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>hbergman@cochrane.org</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Response</DEPARTMENT>
<ORGANISATION>Cochrane</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="939C28C182E26AA201650CEAAFA6885D" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Nicholas</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Henschke</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>nhenschke@cochrane.org</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Response</DEPARTMENT>
<ORGANISATION>Cochrane</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z2101041142408674805492308223739" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Daniel</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Hungerford</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>d.hungerford@liverpool.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute of Infection, Veterinary and Ecological Sciences</DEPARTMENT>
<ORGANISATION>University of Liverpool</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Liverpool</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14326" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Femi</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Pitan</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>fpitan@yahoo.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Chevron Corporation</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Lagos</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NG">Nigeria</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1802061951153875841335668316847" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Duduzile</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Ndwandwe</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>duduzile.ndwandwe@mrc.ac.za</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane South Africa</DEPARTMENT>
<ORGANISATION>South African Medical Research Council </ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Cape Town</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="BE8BBAFF82E26AA200AED5645E3EF3A3" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Nigel</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Cunliffe</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>n.a.cunliffe@liverpool.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute of Infection, Veterinary and Ecological Sciences</DEPARTMENT>
<ORGANISATION>University of Liverpool</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Liverpool</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12341" MODIFIED="2021-10-27 10:24:54 +0100" MODIFIED_BY="59249928586857976988110908155847" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Karla</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Soares-Weiser</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>ksoares-weiser@cochrane.org</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Editorial &amp; Methods Department</DEPARTMENT>
<ORGANISATION>Cochrane</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2021-11-12 14:56:28 +0000" MODIFIED_BY="19988051606560128665111114094226">
<UP_TO_DATE>
<DATE DAY="4" MONTH="4" YEAR="2018"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="11" YEAR="2020"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="4" MONTH="4" YEAR="2020"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="5" YEAR="2010"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2019"/>
</DATES>
<WHATS_NEW/>
<HISTORY/>
<SOURCES_OF_SUPPORT MODIFIED="2019-03-19 15:09:11 +0000" MODIFIED_BY="19988051606560128665111114094226">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT>
<SUMMARY>
<TITLE/>
<SUMMARY_BODY/>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND MODIFIED="2021-11-12 14:56:35 +0000" MODIFIED_BY="19988051606560128665111114094226" NOTES="&lt;p&gt;&lt;span class=&quot;inserted&quot; modified=&quot;2021-11-04 14:42:53 +0000&quot; modified_by=&quot;7492&quot;&gt;you start off by talking about death, but this isn't the importance of this vaccine. &lt;/span&gt;New Note&lt;/p&gt;" NOTES_MODIFIED="2021-11-12 14:56:35 +0000" NOTES_MODIFIED_BY="19988051606560128665111114094226"/>
<ABS_OBJECTIVES/>
<ABS_SEARCH_STRATEGY MODIFIED="2021-11-12 14:56:35 +0000" MODIFIED_BY="19988051606560128665111114094226" NOTES="&lt;p&gt;&lt;span class=&quot;inserted&quot; modified=&quot;2021-11-04 14:43:54 +0000&quot; modified_by=&quot;7492&quot;&gt;why don't you shorten the search using the appraoch in Martin's proposed approach for abstract &lt;/span&gt;New Note&lt;/p&gt;" NOTES_MODIFIED="2021-11-12 14:56:35 +0000" NOTES_MODIFIED_BY="19988051606560128665111114094226"/>
<ABS_SELECTION_CRITERIA/>
<ABS_DATA_COLLECTION/>
<ABS_RESULTS/>
<ABS_CONCLUSIONS/>
</ABSTRACT>
<BODY>
<BACKGROUND>
<CONDITION/>
<INTERVENTION/>
<THEORY/>
<IMPORTANCE/>
</BACKGROUND>
<OBJECTIVES/>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES/>
<CRIT_PARTICIPANTS/>
<CRIT_INTERVENTIONS/>
<CRIT_OUTCOMES>
<CRIT_OUTCOMES_PRIMARY/>
<CRIT_OUTCOMES_SECONDARY/>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<ELECTRONIC_SEARCHES/>
<OTHER_SEARCHES/>
</SEARCH_METHODS>
<DATA_COLLECTION>
<STUDY_SELECTION/>
<DATA_EXTRACTION/>
<QUALITY_ASSESSMENT/>
<EFFECT_MEASURES/>
<UNIT_OF_ANALYSIS/>
<MISSING_DATA/>
<HETEROGENEITY_ASSESSMENT/>
<BIAS_ASSESSMENT/>
<DATA_SYNTHESIS/>
<SUBGROUP_ANALYSIS/>
<SENSITIVITY_ANALYSIS/>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<SEARCH_RESULTS/>
<INCLUDED_STUDIES_DESCR/>
<EXCLUDED_STUDIES_DESCR/>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<ALLOCATION/>
<BLINDING/>
<EXCLUSIONS/>
<SELECTIVE_REPORTING/>
<OTHER_BIAS_SOURCES/>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS/>
</RESULTS>
<DISCUSSION>
<SUMMARY_OF_RESULTS/>
<APPLICABILITY_OF_FINDINGS/>
<QUALITY_OF_EVIDENCE MODIFIED="2021-07-06 16:07:37 +0100" MODIFIED_BY="19988051606560128665111114094226" NOTES="&lt;p&gt;can title be changed to Certainty of the evidence?&#65279;&lt;/p&gt;" NOTES_MODIFIED="2021-07-06 16:07:37 +0100" NOTES_MODIFIED_BY="19988051606560128665111114094226"/>
<POTENTIAL_BIASES/>
<AGREEMENT/>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE/>
<IMPLICATIONS_RESEARCH/>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS/>
<CONFLICT_OF_INTEREST/>
<CONTRIBUTIONS/>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2022-04-25 15:38:58 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2022-04-25 15:38:58 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2022-04-25 15:38:58 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-RIX_x00a0_Anh-2011_x002d_PHL" NAME="RIX Anh 2011-PHL" YEAR="2011">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Anh-2011_x002d_VNM" NAME="RIX Anh 2011-VNM" YEAR="2011">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Bernstein-1998_x002d_USA" NAME="RIX Bernstein 1998-USA" YEAR="1998">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Bernstein-1999_x002d_USA" NAME="RIX Bernstein 1999-USA" YEAR="1999">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Colgate-2016_x002d_BGD" NAME="RIX Colgate 2016-BGD" YEAR="2016">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Dennehy-2005_x002d_NA" NAME="RIX Dennehy 2005-NA" YEAR="2005">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN" NAME="RIX GSK[021] 2007-PAN" YEAR="2007">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA" NAME="RIX GSK[033] 2007-LA" YEAR="2007">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR" NAME="RIX GSK[041] 2007-KOR" YEAR="2007">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL" NAME="RIX GSK[101555] 2008-PHL" YEAR="2008">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Kawamura-2011_x002d_JPN" NAME="RIX Kawamura 2011-JPN" YEAR="2011">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Kerdpanich-2010_x002d_THA" NAME="RIX Kerdpanich 2010-THA" YEAR="2011">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Kim-2012_x002d_KOR" NAME="RIX Kim 2012-KOR" YEAR="2012">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Li-2013a_x002d_CHN" NAME="RIX Li 2013a-CHN" YEAR="2013">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Li-2013b_x002d_CHN" NAME="RIX Li 2013b-CHN" YEAR="2013">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Li-2014_x002d_CHN" NAME="RIX Li 2014-CHN" YEAR="2014">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Madhi-2010_x002d_AF" NAME="RIX Madhi 2010-AF" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Madhi-2010_x002d_MWI" MODIFIED="2022-04-25 15:31:26 +0100" MODIFIED_BY="[Empty name]" NAME="RIX Madhi 2010-MWI" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Madhi-2010_x002d_ZAF" MODIFIED="2022-04-25 15:31:39 +0100" MODIFIED_BY="[Empty name]" NAME="RIX Madhi 2010-ZAF" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Narang-2009_x002d_IND" NAME="RIX Narang 2009-IND" YEAR="2009">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-NCT00158756_x002d_RUS" NAME="RIX NCT00158756-RUS" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Omenaca-2012_x002d_EU" NAME="RIX Omenaca 2012-EU" YEAR="2009">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Phua-2005_x002d_SGP" NAME="RIX Phua 2005-SGP" YEAR="2005">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Phua-2009_x002d_AS" NAME="RIX Phua 2009-AS" YEAR="2009">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Rivera-2011_x002d_DOM" NAME="RIX Rivera 2011-DOM" YEAR="2009">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU" NAME="RIX Ruiz-Palac 06-LA/EU" YEAR="2006">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Salinas-2005_x002d_LA" NAME="RIX Salinas 2005-LA" YEAR="2005">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Steele-2008_x002d_ZAF" NAME="RIX Steele 2008-ZAF" YEAR="2008">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Steele-2010a_x002d_ZAF" MODIFIED="2022-04-25 15:38:58 +0100" MODIFIED_BY="[Empty name]" NAME="RIX Steele 2010a-ZAF" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Steele-2010b_x002d_ZAF" MODIFIED="2022-04-25 15:38:54 +0100" MODIFIED_BY="[Empty name]" NAME="RIX Steele 2010b-ZAF" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Tregnaghi-2011_x002d_LA" NAME="RIX Tregnaghi 2011-LA" YEAR="2011">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Vesikari-2004a_x002d_FIN" NAME="RIX Vesikari 2004a-FIN" YEAR="2004">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Vesikari-2004b_x002d_FIN" NAME="RIX Vesikari 2004b-FIN" YEAR="2004">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Vesikari-2007a_x002d_EU" NAME="RIX Vesikari 2007a-EU" YEAR="2007">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Vesikari-2011_x002d_FIN" NAME="RIX Vesikari 2011-FIN" YEAR="2011">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Ward-2006_x002d_USA" NAME="RIX Ward 2006-USA" YEAR="2006">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Zaman-2009_x002d_BGD" NAME="RIX Zaman 2009-BGD" YEAR="2009">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RIX-Zaman-2017_x002d_BGD" NAME="RIX Zaman 2017-BGD" YEAR="2017">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER" NAME="SIIL Isanaka 2017-NER" YEAR="2017">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-SIIL-Kulkarni-2017_x002d_IND" NAME="SIIL Kulkarni 2017-IND" YEAR="2017">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-SIIL-Zade-2014_x002d_INDa" NAME="SIIL Zade 2014-INDa" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-SIIL-Zade-2014_x002d_INDb" NAME="SIIL Zade 2014-INDb" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-SIIL-Zade-2014_x002d_INDc" NAME="SIIL Zade 2014-INDc" YEAR="2014">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Armah-2010_x002d_AF" NAME="TEQ Armah 2010-AF" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Armah-2010_x002d_GHA" NAME="TEQ Armah 2010-GHA" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Armah-2010_x002d_KEN" NAME="TEQ Armah 2010-KEN" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Armah-2010_x002d_MLI" NAME="TEQ Armah 2010-MLI" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA" NAME="TEQ Block 2007-EU/USA" YEAR="2007">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Ciarlet-2009_x002d_EU" NAME="TEQ Ciarlet 2009-EU" YEAR="2008">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Clark-2003_x002d_USA" NAME="TEQ Clark 2003-USA" YEAR="2003">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Clark-2004_x002d_USA" NAME="TEQ Clark 2004-USA" YEAR="2004">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Dhingra-2014_x002d_IND" NAME="TEQ Dhingra 2014-IND" YEAR="2014">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Iwata-2013_x002d_JPN" NAME="TEQ Iwata 2013-JPN" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Kim-2008_x002d_KOR" NAME="TEQ Kim 2008-KOR" YEAR="2008">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Lawrence-2012_x002d_CHN" NAME="TEQ Lawrence 2012-CHN" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Levin-2017_x002d_AF" NAME="TEQ Levin 2017-AF" YEAR="2017">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA" NAME="TEQ Merck[009] 2005-USA" YEAR="2005">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Mo-2017_x002d_CHN" NAME="TEQ Mo 2017-CHN" YEAR="2016">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Vesikari-2006a_x002d_FIN" NAME="TEQ Vesikari 2006a-FIN" YEAR="2006">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-TEQ-Vesikari-2006b_x002d_INT" NAME="TEQ Vesikari 2006b-INT" YEAR="2006">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Zaman-2010_x002d_AS" NAME="TEQ Zaman 2010-AS" YEAR="2010">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Zaman-2010_x002d_BGD" NAME="TEQ Zaman 2010-BGD" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TEQ-Zaman-2010_x002d_VNM" NAME="TEQ Zaman 2010-VNM" YEAR="">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-VAC-Bhandari-2006_x002d_IND" NAME="VAC Bhandari 2006-IND" YEAR="2006">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-VAC-Bhandari-2009_x002d_IND" NAME="VAC Bhandari 2009-IND" YEAR="2006">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-VAC-Bhandari-2014_x002d_IND" NAME="VAC Bhandari 2014-IND" YEAR="5109">
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-VAC-Chandola-2017_x002d_IND" NAME="VAC Chandola 2017-IND" YEAR="2017">
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES/>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="YES" USER_DEF_1_NAME="Immunization status" USER_DEF_2_ENABLED="YES" USER_DEF_2_NAME="Location" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-RIX_x00a0_Anh-2011_x002d_PHL">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Anh-2011_x002d_VNM">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Bernstein-1998_x002d_USA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Dennehy-2005_x002d_NA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Kawamura-2011_x002d_JPN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Kerdpanich-2010_x002d_THA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Kim-2012_x002d_KOR">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Li-2013a_x002d_CHN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Li-2013b_x002d_CHN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Li-2014_x002d_CHN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Madhi-2010_x002d_AF">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Narang-2009_x002d_IND">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-NCT00158756_x002d_RUS">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Omenaca-2012_x002d_EU">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Phua-2005_x002d_SGP">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Phua-2009_x002d_AS">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Rivera-2011_x002d_DOM">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Salinas-2005_x002d_LA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Steele-2008_x002d_ZAF">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Steele-2010a_x002d_ZAF">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Vesikari-2004a_x002d_FIN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Vesikari-2011_x002d_FIN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Ward-2006_x002d_USA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Zaman-2009_x002d_BGD">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-SIIL-Kulkarni-2017_x002d_IND">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-SIIL-Zade-2014_x002d_INDa">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-SIIL-Zade-2014_x002d_INDb">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-SIIL-Zade-2014_x002d_INDc">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Armah-2010_x002d_AF">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Armah-2010_x002d_GHA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Armah-2010_x002d_KEN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Armah-2010_x002d_MLI">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Ciarlet-2009_x002d_EU">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Clark-2003_x002d_USA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Clark-2004_x002d_USA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Dhingra-2014_x002d_IND">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Iwata-2013_x002d_JPN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Kim-2008_x002d_KOR">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Lawrence-2012_x002d_CHN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Levin-2017_x002d_AF">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Mo-2017_x002d_CHN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Vesikari-2006a_x002d_FIN">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Vesikari-2006b_x002d_INT">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Zaman-2010_x002d_AS">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Zaman-2010_x002d_BGD">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TEQ-Zaman-2010_x002d_VNM">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-VAC-Bhandari-2006_x002d_IND">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-VAC-Bhandari-2009_x002d_IND">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-VAC-Bhandari-2014_x002d_IND">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-VAC-Chandola-2017_x002d_IND">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_USER_DEF_1/>
<CHAR_USER_DEF_2/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="YES" USER_DEF_1_NAME="Immunization status" USER_DEF_2_ENABLED="YES" USER_DEF_2_NAME="Location" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2021-10-20 03:02:41 +0100" MODIFIED_BY="4773" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX_x00a0_Anh-2011_x002d_PHL">
<DESCRIPTION>
<P>Computer-generated<BR/>Quote: "Block randomization scheme (2:2:1 ratio) with standard SAS program was used".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Anh-2011_x002d_VNM">
<DESCRIPTION>
<P>Computer-generated<BR/>Quote: "Block randomization scheme (2:2:1 ratio) with standard SAS program was used".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1998_x002d_USA">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA">
<DESCRIPTION>
<P>Quote: "Infants were assigned to receive either 89-12 or placebo according to a computer-generated randomization schedule (one/one) in blocks of ten provided by the sponsor.</P>
<P>The intention-to-treat analysis included all participants who received at least one dose of study vaccine. Before the code was broken, all cases of rotavirus gastroenteritis and the severity of each episode were verified".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:08 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD">
<DESCRIPTION>
<P>Randomized using permuted blocks with random block size selection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:08 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Dennehy-2005_x002d_NA">
<DESCRIPTION>
<P>Computer-generated, using a SAS programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:08 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN">
<DESCRIPTION>
<P>Computer-generated, using a SAS programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:08 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA">
<DESCRIPTION>
<P>Computer-generated, using a SAS programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR">
<DESCRIPTION>
<P>Computer-generated, using a SAS programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL">
<DESCRIPTION>
<P>Quote: "The ATP cohort for immunogenicity included all vaccinated subjects: &#8211; who had received at least one dose of study vaccine/control according to their random assignment, &#8211; for whom the randomization code had not been broken".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kawamura-2011_x002d_JPN">
<DESCRIPTION>
<P>Computer-generated, using a SAS programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kerdpanich-2010_x002d_THA">
<DESCRIPTION>
<P>Computer-generated, using a SAS programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kim-2012_x002d_KOR">
<DESCRIPTION>
<P>Quote: "All infants receiving RIX4414 or placebo were allocated into their respective groups using an internet based randomization tool SBIR (Internet based randomization system) according to 3:1 ratio".<BR/>Quote: "A standard SAS® program generated a randomization list used to number the vaccines. A randomized (3:1) blocking scheme maintained the balance between the two treatments where a unique treatment number identified the study vaccine to be administered to the infants".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013a_x002d_CHN">
<DESCRIPTION>
<P>Treatment allocation at the investigator site was performed using an internet-based randomization system (SBIR).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013b_x002d_CHN">
<DESCRIPTION>
<P>Treatment allocation at the investigator site was performed using an internet-based randomization system (SBIR)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2014_x002d_CHN">
<DESCRIPTION>
<P>Randomization sequence generated using software (MATEX developed for SAS)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_AF">
<DESCRIPTION>
<P>A randomization list was generated at GSK Biologicals, Rixensart, using a standard SAS® (Statistical Analysis System) program and this was used to number the vaccines.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI">
<DESCRIPTION>
<P>A randomization list was generated at GSK Biologicals, Rixensart, using a standard SAS® (Statistical Analysis System) program and this was used to number the vaccines.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF">
<DESCRIPTION>
<P>A randomization list was generated at GSK Biologicals, Rixensart, using a standard SAS® (Statistical Analysis System) program and this was used to number the vaccines.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Narang-2009_x002d_IND">
<DESCRIPTION>
<P>Computer-generated, using a SAS program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-NCT00158756_x002d_RUS">
<DESCRIPTION>
<P>Randomized (4:1:4:1:5) using GSK Biologicals central randomization system (SBIR)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Omenaca-2012_x002d_EU">
<DESCRIPTION>
<P>Computer-generated block randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Phua-2005_x002d_SGP">
<DESCRIPTION>
<P>Computer-generated, using a SAS program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Phua-2009_x002d_AS">
<DESCRIPTION>
<P>A randomization list was generated at GSK Biologicals, Rixensart, using a standard SAS® program and was used to number the vaccines.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Rivera-2011_x002d_DOM">
<DESCRIPTION>
<P>Quote: "A randomization list was generated at GlaxoSmithKline (GSK) Biologicals, Rixensart, using a standard SAS<SUP>® </SUP>program. A randomization blocking scheme (1:1 ratio, block size = 2) was used to ensure balance between the treatment arms; a treatment number uniquely identified the vaccine doses to be administered to the same infant".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU">
<DESCRIPTION>
<P>Quote: "GlaxoSmithKline Biologicals provided vaccine supplies that were numbered with a computer-generated randomization list. We used a blocking scheme randomization. GSK did the masking and concealment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA">
<DESCRIPTION>
<P>Computer-generated<BR/>Quote:"The participating infants were randomly assigned to one of the 4 study groups (3 vaccine groups and a placebo group) following a 1:1:1:1 allocation ratio according to a computer-generated randomization list".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2008_x002d_ZAF">
<DESCRIPTION>
<P>Very likely<BR/>Quote: "This study was conducted under the WHO RAPID (Rotavirus Action Partnership for Immunization and Development) programme that facilitates conduct of rotavirus vaccine trials in developing countries, specifically in Africa and Asia, to address specific developing country needs. The RAPID partnership consists of public sector partners (including the WHO, US Agency for International Development, National Institutes of Health, Children&#8217;s Vaccine Programme and the Centers for Disease Control), academic institutions (International Centre for Diarrhoeal Disease Research, Bangladesh and Medical University of Southern Africa) and GlaxoSmithKline Biologicals".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010a_x002d_ZAF">
<DESCRIPTION>
<P>Very likely <BR/>Quote: "This study was conducted under the WHO RAPID (Rotavirus Action Partnership for Immunization and Development) programme that facilitates conduct of rotavirus vaccine trials in developing countries, specifically in Africa and Asia, to address specific developing country needs. The RAPID partnership consists of public sector partners (including the WHO, US Agency for International Development, National Institutes of Health, Children&#8217;s Vaccine Programme and the Centers for Disease Control), academic institutions (International Centre for Diarrhoeal Disease Research, Bangladesh and Medical University of Southern Africa) and GlaxoSmithKline Biologicals".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF">
<DESCRIPTION>
<P>Very likely. This study was conducted under the auspices of WHO (eTrack 444563/013/NCT00383903)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA">
<DESCRIPTION>
<P>Computer-generated, using a SAS program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004a_x002d_FIN">
<DESCRIPTION>
<P>Computer-generated, using a SAS program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN">
<DESCRIPTION>
<P>Quote: "Eligible infants were randomly assigned (2:1 ratio) to 2 study groups according to a computer-generated randomization list to receive the vaccine or placebo by mouth".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU">
<DESCRIPTION>
<P>Quote: "GSK Biologicals provided vaccine supplies that were numbered with a computer-generated randomization list".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2011_x002d_FIN">
<DESCRIPTION>
<P>Computer-generated<BR/>Quote: "A standard SAS<SUP>® </SUP>program was used for generating the randomization list and a block randomization was used in order to ensure that the balance between the treatment arms were maintained".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Ward-2006_x002d_USA">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Zaman-2009_x002d_BGD">
<DESCRIPTION>
<P>Computer-generated, using a SAS program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD">
<DESCRIPTION>
<P>Villages were randomized in a 1:1 ratio for introduction of HRV or not. Prior to study initiation, PATH computer generated the allocation sequences using block randomization with block sizes of 12.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 07:29:58 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER">
<DESCRIPTION>
<P>Quote: "Unique assignment numbers were prepared with the use of a computer-generated random-number list with nondisclosed permuted blocks of random sizes (DiagnoSearch Life Sciences)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 08:11:06 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Kulkarni-2017_x002d_IND">
<DESCRIPTION>
<P>Quote: "computer-generated allocation schedule"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 12:59:04 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDa">
<DESCRIPTION>
<P>Quote: "Permuted block randomization, fixed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:00:15 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDb">
<DESCRIPTION>
<P>Quote: "Permuted block randomization, fixed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:09:46 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDc">
<DESCRIPTION>
<P>Quote: "Permuted block randomization, fixed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_AF">
<DESCRIPTION>
<P>Quote: "Unique allocation numbers were designated at Merck as pentavalent rotavirus vaccine or placebo with computer generated block randomization, with block sizes of six".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_GHA">
<DESCRIPTION>
<P>Quote: "Unique allocation numbers were designated at Merck as pentavalent rotavirus vaccine or placebo with computer generated block randomization, with block sizes of six".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_KEN">
<DESCRIPTION>
<P>Quote: "Unique allocation numbers were designated at Merck as pentavalent rotavirus vaccine or placebo with computer generated block randomization, with block sizes of six".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_MLI">
<DESCRIPTION>
<P>Quote: "Unique allocation numbers were designated at Merck as pentavalent rotavirus vaccine or placebo with computer generated block randomization, with block sizes of six".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA">
<DESCRIPTION>
<P>Quote: "Enrolled infants were randomly assigned 1:1 by using computer-generated allocation schedules to receive either vaccine or visibly indistinguishable placebo in a sucrose citrate buffer administered orally as three 2-mL doses 4 to 10 weeks apart".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Ciarlet-2009_x002d_EU">
<DESCRIPTION>
<P>Computer-generated randomized 1:1 to receive hexavalent vaccine concomitantly with either RotaTeq or placebo (Merck 2012)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2003_x002d_USA">
<DESCRIPTION>
<P>No details<BR/>Quote: "Children who met all eligibility criteria were randomized to one of eight treatment groups".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2004_x002d_USA">
<DESCRIPTION>
<P>Quote: "Infants who met all eligibility criteria were randomly assigned in a 1:1 ratio". No further details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Dhingra-2014_x002d_IND">
<DESCRIPTION>
<P>Computer-generated randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:09 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Iwata-2013_x002d_JPN">
<DESCRIPTION>
<P>Quote: "Allocation number was assigned and the subject was randomized to the group receiving RotaTeq or the group receiving placebo in a 1:1 ratio according to the randomization code prepared by a computer at the US Merck Headquarters Office" (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Kim-2008_x002d_KOR">
<DESCRIPTION>
<P>Computer-generated randomized 2:1 to receive hexavalent vaccine concomitantly with either RotaTeq or placebo (Merck 2012)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Lawrence-2012_x002d_CHN">
<DESCRIPTION>
<P>All participants were randomized according to a computer-generated allocation schedule (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Levin-2017_x002d_AF">
<DESCRIPTION>
<P>Study reported to be randomized, but no details provided on the randomization process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA">
<DESCRIPTION>
<P>Computer-generated randomization to 1 of 4 treatment groups. A randomization scheme of 2:2:2:1, with a blocking factor of 14 was used, and participants received either 1 of 3 lots of RotaTeq or placebo (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Mo-2017_x002d_CHN">
<DESCRIPTION>
<P>Study reported to be randomized, but no details provided on the randomization process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006a_x002d_FIN">
<DESCRIPTION>
<P>Computer-generated (Merck 2012)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006b_x002d_INT">
<DESCRIPTION>
<P>Computer-generated randomized 1:1 to receive either RotaTeq or placebo (Merck 2012)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_AS">
<DESCRIPTION>
<P>Quote: "Unique allocation numbers were designated at Merck as pentavalent rotavirus vaccine or placebo with computer generated block randomization, with block sizes of six".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_BGD">
<DESCRIPTION>
<P>Quote: "Unique allocation numbers were designated at Merck as pentavalent rotavirus vaccine or placebo with computer generated block randomization, with block sizes of six".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_VNM">
<DESCRIPTION>
<P>Quote: "Unique allocation numbers were designated at Merck as pentavalent rotavirus vaccine or placebo with computer generated block randomization, with block sizes of six".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2006_x002d_IND">
<DESCRIPTION>
<P>Quote: "For randomisation, a sequence of codes was generated using Stata, version 8 (Statacorp, College Station, TX, USA) by a statistician not otherwise involved with the trial."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2009_x002d_IND">
<DESCRIPTION>
<P>Infants were assigned to either the vaccine or placebo groups in a 1:1 ratio with use of a randomization sequence generated by a statistician not otherwise involved with the study (Stata software, version 8.0) with a fixed block length of 4.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2014_x002d_IND">
<DESCRIPTION>
<P>Randomization was performed by Cenduit, LLC, Germany, with stratification by site, and a block size of 12.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Chandola-2017_x002d_IND">
<DESCRIPTION>
<P>Quote: "Randomization was done by Diagnosearch Life Sciences Pvt. Ltd. and the randomization list was available with an independent biostatistician".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2021-10-20 03:02:41 +0100" MODIFIED_BY="4773" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX_x00a0_Anh-2011_x002d_PHL">
<DESCRIPTION>
<P>Central allocation<BR/>Quote: "Based on the block size, the vaccine doses were distributed to each of the study centers".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Anh-2011_x002d_VNM">
<DESCRIPTION>
<P>Central allocation<BR/>Quote: "Based on the block size, the vaccine doses were distributed to each of the study centers".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1998_x002d_USA">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA">
<DESCRIPTION>
<P>As above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD">
<DESCRIPTION>
<P>All clinical investigators and laboratories were masked to vaccine arm, but medical officers were not.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Dennehy-2005_x002d_NA">
<DESCRIPTION>
<P>Central allocation<BR/>Quote: "double blind randomized unbalanced allocation scheme (2:2:1 ratio)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kawamura-2011_x002d_JPN">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kerdpanich-2010_x002d_THA">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kim-2012_x002d_KOR">
<DESCRIPTION>
<P>The person in charge of the vaccination accessed the randomization system on the Internet. Upon providing a participant number and the age (6 - 12 weeks) for the infant, the randomization system used the minimization algorithm to determine the treatment number to be used for the participant.<BR/>The actual treatment number used for first vaccination of the participant was recorded by the investigator in the eCRF (randomisation/treatment allocation section)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013a_x002d_CHN">
<DESCRIPTION>
<P>Treatment allocation at the investigator site was performed using an internet-based randomization system (SBIR).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013b_x002d_CHN">
<DESCRIPTION>
<P>Treatment allocation at the investigator site was performed using an internet-based randomization system (SBIR)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2014_x002d_CHN">
<DESCRIPTION>
<P>Treatment allocation at the investigator site was performed using SBIR (internet randomization tool).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_AF">
<DESCRIPTION>
<P>The vaccine doses were distributed to each study centre while respecting the randomization block size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI">
<DESCRIPTION>
<P>The vaccine doses were distributed to each study centre while respecting the randomizations block size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF">
<DESCRIPTION>
<P>The vaccine doses were distributed to each study centre while respecting the randomization block size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Narang-2009_x002d_IND">
<DESCRIPTION>
<P>Likely to be adequate: treatment masked to investigators<BR/>Quote: "a treatment number identified uniquely the vaccine doses to be administered to the same subject" and "subjects were administered the vaccine dose with the lowest treatment number available at the study centre".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-NCT00158756_x002d_RUS">
<DESCRIPTION>
<P>Cental allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Omenaca-2012_x002d_EU">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Phua-2005_x002d_SGP">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Phua-2009_x002d_AS">
<DESCRIPTION>
<P>A randomization blocking scheme was used to ensure that the balance between treatments was maintained. Treatment allocation at the investigator sites was performed using a central randomization system on the Internet.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Rivera-2011_x002d_DOM">
<DESCRIPTION>
<P>Quote: "No investigator or any person involved in the clinical trial (including laboratory personnel, statisticians and data management) was aware of the treatment groups during the course of the study".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU">
<DESCRIPTION>
<P>Quote: "Randomization was done by a central Internet randomization system".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:10 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Steele-2008_x002d_ZAF">
<DESCRIPTION>
<P>Likely to be adequate: treatment masked to investigators<BR/>Quote: "a unique randomization number identified the vials to be administered to the same subject" and "subjects were administered the vaccine dose with the lowest treatment number available at the study centre".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Steele-2010a_x002d_ZAF">
<DESCRIPTION>
<P>1:1 randomization; no further details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF">
<DESCRIPTION>
<P>Likely to be adequate: treatment masked to investigators<BR/>Quote: "a randomization number uniquely identified the three vials to be administered to the same subject" and "subjects were administered the vaccine dose with the lowest number available at the study centre".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004a_x002d_FIN">
<DESCRIPTION>
<P>Likely to be adequate: treatment masked to investigators<BR/>Quote: "A randomisation or subject number identified uniquely the vaccine dose to be administered to the subject", and "subjects were administered the vaccine dose with the lowest number available at the study site".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN">
<DESCRIPTION>
<P>Likely to be adequate: treatment masked to investigators<BR/>Quote: "A randomisation or subject number identified uniquely the vaccine dose to be administered to each subject", and "subjects were administered the vaccine dose with the lowest number available at the study site".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU">
<DESCRIPTION>
<P>Quote: "randomization was done by a central Internet randomization system. Infants were randomly allocated in a 2/1 ratio two doses of either RIX4414 or placebo".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2011_x002d_FIN">
<DESCRIPTION>
<P>Likely to be adequate: treatment masked to investigators<BR/>Quote: "a unique randomization number identified the vials to be administered to the same subject" and "subjects were administered the vaccine dose with the lowest treatment number available at the study centre".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Ward-2006_x002d_USA">
<DESCRIPTION>
<P>Quote: "double-blinded, placebo-controlled study designed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Zaman-2009_x002d_BGD">
<DESCRIPTION>
<P>Likely to be adequate: treatment masked to investigators<BR/>Quote: "A treatment number identified uniquely the vaccine doses to be administered to the same subject", and "subjects were administered the study vaccine dose (HRV vaccine or placebo) with the lowest number available at the study site".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD">
<DESCRIPTION>
<P>The generated allocation sequences were securely transferred to the principal investigator, who distributed the sequences to the field supervisors who oversaw HRV vaccinations.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 07:30:17 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were labeled with assignment numbers with identical presentation. All the practitioners and participants were unaware of the treatment assignments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 08:11:07 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Kulkarni-2017_x002d_IND">
<DESCRIPTION>
<P>Quote: "assignments were provided to the sites by a validated interactive web response system".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 12:59:12 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDa">
<DESCRIPTION>
<P>Quote: "Pre-numbered or coded identical Containers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:00:21 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDb">
<DESCRIPTION>
<P>Quote: "Pre-numbered or coded identical Containers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:09:51 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDc">
<DESCRIPTION>
<P>Quote: "Pre-numbered or coded identical Containers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_AF">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were then labelled with allocation numbers and provided to sites in identical presentations. Sites were instructed to assign allocation numbers to participants in sequential order as they were enrolled".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_GHA">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were then labelled with allocation numbers and provided to sites in identical presentations. Sites were instructed to assign allocation numbers to participants in sequential order as they were enrolled".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_KEN">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were then labelled with allocation numbers and provided to sites in identical presentations. Sites were instructed to assign allocation numbers to participants in sequential order as they were enrolled".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_MLI">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were then labelled with allocation numbers and provided to sites in identical presentations. Sites were instructed to assign allocation numbers to participants in sequential order as they were enrolled".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA">
<DESCRIPTION>
<P>Sequential identical containers (see quote above)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Ciarlet-2009_x002d_EU">
<DESCRIPTION>
<P>Allocation numbers were generated for participants, investigators, adults, and parents/guardians of children were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2003_x002d_USA">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2004_x002d_USA">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Dhingra-2014_x002d_IND">
<DESCRIPTION>
<P>Likely to be adequate:<BR/>Quote: "Pre-numbered or coded identical containers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Iwata-2013_x002d_JPN">
<DESCRIPTION>
<P>Allocation numbers were generated and allocated centrally for participants (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Kim-2008_x002d_KOR">
<DESCRIPTION>
<P>Allocation numbers were generated for participants; investigators, adults, and parents/guardians of children were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Lawrence-2012_x002d_CHN">
<DESCRIPTION>
<P>Allocation numbers were generated for participants; investigators, adults, and parents/guardians of children were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Levin-2017_x002d_AF">
<DESCRIPTION>
<P>No details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA">
<DESCRIPTION>
<P>Allocation numbers were generated for participants; investigators, adults, and parents/guardians of children were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Mo-2017_x002d_CHN">
<DESCRIPTION>
<P>No details reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006a_x002d_FIN">
<DESCRIPTION>
<P>Allocation numbers were generated for participants; investigators and parents/guardians were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006b_x002d_INT">
<DESCRIPTION>
<P>Allocation numbers were generated for participants; investigators and parents/guardians were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_AS">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were then labelled with allocation numbers and provided to sites in identical presentations. Sites were instructed to assign allocation numbers to participants in sequential order as they were enrolled".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_BGD">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were then labelled with allocation numbers and provided to sites in identical presentations. Sites were instructed to assign allocation numbers to participants in sequential order as they were enrolled".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_VNM">
<DESCRIPTION>
<P>Quote: "Vaccine and placebo packages were then labelled with allocation numbers and provided to sites in identical presentations. Sites were instructed to assign allocation numbers to participants in sequential order as they were enrolled".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2006_x002d_IND">
<DESCRIPTION>
<P>Quote: "Two copies of the randomisation code were prepared; one was sent to the Division of Microbiology and Infectious Diseases (DMID) at the NIH under sealed cover, and the second was given to a physician, not otherwise involved in the study, for reconstituting the vaccine/placebo at the time of enrolment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2009_x002d_IND">
<DESCRIPTION>
<P>Allocation concealment was achieved by using serially-numbered sealed opaque envelopes. One set of envelopes was available with the independent vaccine-dispensing team and another with the study data safety monitoring board.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2014_x002d_IND">
<DESCRIPTION>
<P>The letter code on the vaccine/placebo vial was masked with the participant identification number before sending the vial to the clinical co-ordinator administering the test article to the enrolled infant.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Chandola-2017_x002d_IND">
<DESCRIPTION>
<P>Central allocation</P>
<P>Quote: "Randomization was done by Diagnosearch Life Sciences Pvt. Ltd. and the randomization list was available with an independent biostatistician".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX_x00a0_Anh-2011_x002d_PHL">
<DESCRIPTION>
<P>Participants and key personnel were blinded.<BR/>Quote: "The study was double-blind with respect to the RIX4414 oral suspension (liquid formulation), placebo and scheduling of doses. The parents/guardians of infants, investigators and study personnel were unaware of the study vaccine/placebo administered".<BR/>Quote: "The placebo was identical to the vaccine in composition".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Anh-2011_x002d_VNM">
<DESCRIPTION>
<P>Participants and key personnel were blinded.<BR/>Quote: "The study was double-blind with respect to the RIX4414 oral suspension (liquid formulation), placebo and scheduling of doses. The parents/guardians of infants, investigators and study personnel were unaware of the study vaccine/ placebo administered".<BR/>Quote: "The placebo was identical to the vaccine in composition".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1998_x002d_USA">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA">
<DESCRIPTION>
<P>Double-blind, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="NO" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD">
<DESCRIPTION>
<P>Rotarix versus no intervention, unable to blind (no placebo)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Dennehy-2005_x002d_NA">
<DESCRIPTION>
<P>Participants and key personnel; Quote: "Study personnel and families were blinded to group assignment until study completion".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL">
<DESCRIPTION>
<P>No details; Quote: "Double-blind with respect to each HRV [Rotarix] vaccine formulation and its respective placebo"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:11 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kawamura-2011_x002d_JPN">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-RIX-Kerdpanich-2010_x002d_THA">
<DESCRIPTION>
<P>Partially blind study. Quote: &#8220;Single blind&#8221;; not reported whether personnel or participants were blinded<BR/>Quote: &#8220;The placebo was identical in appearance and composition to the active vaccine&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kim-2012_x002d_KOR">
<DESCRIPTION>
<P>Quote: "Each dose of RIX4414 or placebo was administered in a blinded manner where the parents/guardians and the physicians were unaware of the vaccine administered".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013a_x002d_CHN">
<DESCRIPTION>
<P>The study was conducted in a double-blind manner with respect to HRV vaccine and placebo. The parents/LARs of the infants, the study personnel and the investigator were unaware of the study vaccine administered (liquid HRV vaccine or placebo). The laboratory in charge of the laboratory testing was blinded to the treatment, and codes were used to link the participant and study (without any link to the treatment attributed to the participant) to each sample.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013b_x002d_CHN">
<DESCRIPTION>
<P>The study was conducted in a double-blind manner with respect to HRV vaccine and placebo. The parents/LARs of the infants, the study personnel and the investigator were unaware of the study vaccine administered (liquid HRV vaccine or placebo). The laboratory in charge of the laboratory testing was blinded to the treatment, and codes were used to link the participant and study (without any link to the treatment attributed to the participant) to each sample.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2014_x002d_CHN">
<DESCRIPTION>
<P>Concealed from parents/guardians, study personnel, and investigators; placebo-controlled study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_AF">
<DESCRIPTION>
<P>The site investigator was unaware of the group assignments of the children.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI">
<DESCRIPTION>
<P>The site investigator was unaware of the group assignments of the children.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF">
<DESCRIPTION>
<P>The site investigator was unaware of the group assignments of the children.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Narang-2009_x002d_IND">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-NCT00158756_x002d_RUS">
<DESCRIPTION>
<P>The study was conducted in a double-blind manner with respect to the Rotarix and placebo groups and in single-blinded manner with respect to the Tritanrix-HepB and Zilbrix groups. The study was open with respect to the Triple Antigen + Engerix-B group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Omenaca-2012_x002d_EU">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Phua-2005_x002d_SGP">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Phua-2009_x002d_AS">
<DESCRIPTION>
<P>Data analysis was performed at GSK Biologicals. The treatment code remained masked, except for statisticians and the database administrator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Rivera-2011_x002d_DOM">
<DESCRIPTION>
<P>Quote: "The study was double-blinded and the parents/guardians of infants, investigator and the study personnel were unaware of the study vaccine administered".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU">
<DESCRIPTION>
<P>Quote: "Treatment allocation remained concealed from investigators and parents of participating infants throughout the study. GSK did the masking and concealment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA">
<DESCRIPTION>
<P>Quote: "Double blinding was maintained during the entire study period".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Steele-2008_x002d_ZAF">
<DESCRIPTION>
<P>Blinding of oral polio vaccine co-administration not completely blinded<BR/>Quote: "OPV and its placebo used in the first cohort were identical in appearance allowing for double blinding while this was not possible in the second cohort due to differences in appearance of OPV and its placebo".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010a_x002d_ZAF">
<DESCRIPTION>
<P>Quote: "The placebo was similar to RIX4414 in appearance and contained the same constituents as the active vaccine except that it did not contain the vaccine virus".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF">
<DESCRIPTION>
<P>Quote: "The placebo was similar to RIX4414 in appearance and contained the same constituents as the active vaccine except that it did not contain the vaccine virus".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Vesikari-2004a_x002d_FIN">
<DESCRIPTION>
<P>Quote: "The study was performed under double-blind with respect to the groups within each study part".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN">
<DESCRIPTION>
<P>Quote: "The placebo had the same constituents and identical appearance as the active vaccine, but did not contain the vaccine virus".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU">
<DESCRIPTION>
<P>Quote: "Treatment allocation remained concealed from investigators and the parents of participating infants throughout the study".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2011_x002d_FIN">
<DESCRIPTION>
<P>Participants and key personnel were blinded as far as technically possible.<BR/>Quote: "The study was double blind with respect to each of the vaccine formulation and their respective placebo; however, blinding between the two vaccine formulations was not technically possible because of the difference in appearance of the vaccines".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Ward-2006_x002d_USA">
<DESCRIPTION>
<P>Quote: "double-blinded, placebo-controlled study designed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Zaman-2009_x002d_BGD">
<DESCRIPTION>
<P>Parent/guardian and study personnel were not aware of the treatment administered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="NO" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD">
<DESCRIPTION>
<P>The study was conducted open-label without masking, and field staff conducting the vaccinations were unblinded. Medical staff collecting clinical data on diarrhoeal presentations and laboratory personnel conducting assays on stools were not informed of previous HRV receipt of participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2021-03-10 08:08:00 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER">
<DESCRIPTION>
<P>Participants, carers, investigators, Data Safety Monitoring Board, and statistician were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2021-03-10 08:17:40 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Kulkarni-2017_x002d_IND">
<DESCRIPTION>
<P>Quote: "All the study vaccine containers looked identical with unique vial numbers printed on them to maintain blinding."<BR/>Comment: Participants, carers, and study personnel/investigators were probably blinded. No details on blinding of outcome assessment were reported. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2021-03-14 12:59:20 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDa">
<DESCRIPTION>
<P>Quote: "Participant, Investigator and Outcome Assessor Blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2021-03-14 13:00:29 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDb">
<DESCRIPTION>
<P>Quote: "Participant, Investigator and Outcome Assessor Blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2021-03-14 13:10:00 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDc">
<DESCRIPTION>
<P>Quote: "Participant, Investigator and Outcome Assessor Blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_AF">
<DESCRIPTION>
<P>Participants and staff:<BR/>Quote: "Participants were enrolled by study staff, who remained masked to treatment assignment throughout the trial".</P>
<P>Researchers:<BR/>Quote: "The statistician from Merck who analysed the data and the Merck and PATH protocol teams were masked to treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_GHA">
<DESCRIPTION>
<P>Participants and staff:<BR/>Quote: "Participants were enrolled by study staff, who remained masked to treatment assignment throughout the trial".</P>
<P>Researchers:<BR/>Quote: "The statistician from Merck who analysed the data and the Merck and PATH protocol teams were masked to treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_KEN">
<DESCRIPTION>
<P>Participants and staff:<BR/>Quote: "Participants were enrolled by study staff, who remained masked to treatment assignment throughout the trial".</P>
<P>Researchers:<BR/>Quote: "The statistician from Merck who analysed the data and the Merck and PATH protocol teams were masked to treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_MLI">
<DESCRIPTION>
<P>Participants and staff:<BR/>Quote: "Participants were enrolled by study staff, who remained masked to treatment assignment throughout the trial".</P>
<P>Researchers:<BR/>Quote: "The statistician from Merck who analysed the data and the Merck and PATH protocol teams were masked to treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA">
<DESCRIPTION>
<P>Quote:"This randomized, clinical trial blinded to investigator, parent or guardian, and sponsor"</P>
<P>"The placebo was identical to the vaccine except that it did not contain the rotavirus reassortants or trace trypsin".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Ciarlet-2009_x002d_EU">
<DESCRIPTION>
<P>RotaTeq was visibly indistinguishable from placebo; investigators, parents/guardians and study personnel (internal and external) were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Clark-2003_x002d_USA">
<DESCRIPTION>
<P>Participants and key personnel:<BR/>Quote: "Parents of participating infants and study personnel were blinded to receipt of vaccine/placebo but not to the volume administered or to the prefeeding requirement".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Clark-2004_x002d_USA">
<DESCRIPTION>
<P>Quote: "The vials of vaccine and placebo were visibly indistinguishable".</P>
<P>Quote: "The placebo was identical to the vaccine except that it did not contain the rotavirus reassortants". Investigators, study personnel (internal and external), and parents/guardians were blinded throughout the trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="NO" STUDY_ID="STD-TEQ-Dhingra-2014_x002d_IND">
<DESCRIPTION>
<P>Single-blind, participant and outcome assessor-blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Iwata-2013_x002d_JPN">
<DESCRIPTION>
<P>RotaTeq was visibly indistinguishable from placebo; investigators, study personnel (internal and external) and parents/guardians were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Kim-2008_x002d_KOR">
<DESCRIPTION>
<P>RotaTeq was visibly indistinguishable from placebo; investigators, study personnel (internal and external), and parents/guardians were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Lawrence-2012_x002d_CHN">
<DESCRIPTION>
<P>RotaTeq was visibly indistinguishable from placebo; investigators, study personnel (internal and external) and parents/guardians were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Levin-2017_x002d_AF">
<DESCRIPTION>
<P>Placebo-controlled but no details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA">
<DESCRIPTION>
<P>RotaTeq was visibly indistinguishable from placebo; investigators, study personnel (internal and external) and parents/guardians were blinded throughout trial (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:12 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Mo-2017_x002d_CHN">
<DESCRIPTION>
<P>Blinded for vaccine versus placebo, not for staggered versus concomitant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006a_x002d_FIN">
<DESCRIPTION>
<P>Sequential identical containers:<BR/>Quote: "The vials containing either vaccine or placebo were visibly indistinguishable."</P>
<P>Participants and key personnel:<BR/>Quote: "This randomized clinical trial blinded to subject, investigator, parent/legal guardian, and sponsor. The placebo was identical to the vaccine except that it did not contain rotavirus reassortants or trace trypsin".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006b_x002d_INT">
<DESCRIPTION>
<P>Participants and key personnel:</P>
<P>Quote: "Randomized, multicenter, double blinded (operated under in-house blinding procedures), placebo controlled, safety and efficacy trial. The placebo was an exact match minus the virus".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_AS">
<DESCRIPTION>
<P>Participants and staff:</P>
<P>Quote: "Participants were enrolled by study staff, who remained masked to treatment assignment throughout the trial".</P>
<P>Researchers:</P>
<P>Quote: "The statistician from Merck who analysed the data and the Merck and PATH protocol teams were masked to treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_BGD">
<DESCRIPTION>
<P>Participants and staff:</P>
<P>Quote: "Participants were enrolled by study staff, who remained masked to treatment assignment throughout the trial".</P>
<P>Researchers:</P>
<P>Quote: "The statistician from Merck who analysed the data and the Merck and PATH protocol teams were masked to treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_VNM">
<DESCRIPTION>
<P>Participants and staff:</P>
<P>Quote: "Participants were enrolled by study staff, who remained masked to treatment assignment throughout the trial".</P>
<P>Researchers:</P>
<P>Quote: "The statistician from Merck who analysed the data and the Merck and PATH protocol teams were masked to treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2006_x002d_IND">
<DESCRIPTION>
<P>Quote: "Double-blind"<BR/>Quote: "The placebo was constituted by adding a crystal of potassium permanganate to sodium bicarbonate buffer and appeared identical to the vaccines but did not contain the virus."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-VAC-Bhandari-2009_x002d_IND">
<DESCRIPTION>
<P>Study reported to be double-blind but no further details were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2014_x002d_IND">
<DESCRIPTION>
<P>The placebo was identical in content, packaging, and appearance to the vaccine but did not contain the virus.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Chandola-2017_x002d_IND">
<DESCRIPTION>
<P>Quote: "The placebo was identical in content, packaging, and appearance to the vaccine. The study team received ROTAVAC® or placebo vials labeled with the subject Identification (ID) number to maintain blinding. The study team, vaccine administrators and laboratory personnel were not aware of the treatment status."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2021-10-20 03:02:41 +0100" MODIFIED_BY="4773" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX_x00a0_Anh-2011_x002d_PHL">
<DESCRIPTION>
<P>Attrition balanced across groups with reasons for dropout/exclusion reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Anh-2011_x002d_VNM">
<DESCRIPTION>
<P>Attrition balanced across groups with reasons for dropout/exclusion reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1998_x002d_USA">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA">
<DESCRIPTION>
<P>No impact on intervention effect estimate</P>
<P>Quote: "Of the 215 children enrolled, 213 received both doses of vaccine or placebo, and 214 were followed up for gastrointestinal disease. One child in the vaccine group did not receive the vaccine because of persistent fever at the time of the scheduled revaccination, and one child in the placebo group was found to have a congenital tracheal malformation while in the trial and was not revaccinated".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD">
<DESCRIPTION>
<P>Primary ITT analysis, moderate attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Dennehy-2005_x002d_NA">
<DESCRIPTION>
<P>Missing data balanced across groups<BR/>Quote: "Fifty-nine subjects, who were proportionately distributed among vaccine groups, did not complete the entire 10- to 12-month study".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN">
<DESCRIPTION>
<P>203/228 participants completed the study. Reasons for withdrawal were reported and balanced between groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA">
<DESCRIPTION>
<P>795/854 completed the study. Reasons for dropping out were reported and were balanced between study groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR">
<DESCRIPTION>
<P>4/103 participants in the vaccine arm did not complete the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL">
<DESCRIPTION>
<P>5/100 participants withdrawn from the vaccine group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kawamura-2011_x002d_JPN">
<DESCRIPTION>
<P>Attrition/exclusions balanced between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Kerdpanich-2010_x002d_THA">
<DESCRIPTION>
<P>Attrition balanced across groups with reasons for withdrawal reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Kim-2012_x002d_KOR">
<DESCRIPTION>
<P>462/684 completed the study; reasons for attrition provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013a_x002d_CHN">
<DESCRIPTION>
<P>All participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013b_x002d_CHN">
<DESCRIPTION>
<P>All participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2014_x002d_CHN">
<DESCRIPTION>
<P>Reasons for attrition provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_AF">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Narang-2009_x002d_IND">
<DESCRIPTION>
<P>Attrition/exclusions balanced between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-NCT00158756_x002d_RUS">
<DESCRIPTION>
<P>All participants included in analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Omenaca-2012_x002d_EU">
<DESCRIPTION>
<P>Missing data balanced between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Phua-2005_x002d_SGP">
<DESCRIPTION>
<P>Missing data imputed appropriately</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Phua-2009_x002d_AS">
<DESCRIPTION>
<P>Primary analysis of efficacy was performed from 2 weeks post-dose 2 until 2 years of age on the ATP cohort that included participants who completed the full 2-dose vaccination course and complied with the protocol. The total vaccinated cohort was used to calculate vaccine efficacy starting from the first dose onwards.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Rivera-2011_x002d_DOM">
<DESCRIPTION>
<P>Attrition/exclusions balanced between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU">
<DESCRIPTION>
<P>Quote: "full GSK report account for all withdrawals regardless of reason"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2008_x002d_ZAF">
<DESCRIPTION>
<P>Quote: "All infants who had received at least one dose of RIX4414 or placebo (total vaccinated cohort) were included in the primary analysis of reactogenicity".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010a_x002d_ZAF">
<DESCRIPTION>
<P>Quote: "All infants who had received at least one dose of RIX4414 or placebo (total vaccinated cohort) were included in the primary analysis of reactogenicity".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF">
<DESCRIPTION>
<P>Quote: "All infants who had received at least one dose of RIX4414 or placebo (total vaccinated cohort) were included in the primary analysis of reactogenicity".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA">
<DESCRIPTION>
<P>96.7% completed the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004a_x002d_FIN">
<DESCRIPTION>
<P>14/192 participants dropped out of the study; balanced between groups with reasons provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN">
<DESCRIPTION>
<P>33/405 participants dropped out of the study; balanced between groups with reasons provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU">
<DESCRIPTION>
<P>Missing data imputed appropriately</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2011_x002d_FIN">
<DESCRIPTION>
<P>Attrition balanced across study groups with reasons for dropout/exclusion reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Ward-2006_x002d_USA">
<DESCRIPTION>
<P>No impact on intervention effect estimate<BR/>Quote: "Of the 80 vaccine recipients in this trial, 2 had evidence of natural rotavirus infection before administration of the first dose, determined on the basis of rotavirus IgA in their serum. These, along with the 3 who received only 1 dose of vaccine, were eliminated from further analyses".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Zaman-2009_x002d_BGD">
<DESCRIPTION>
<P>Missing data imputed appropriately</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD">
<DESCRIPTION>
<P>Outcome data available for 11,004/12,318 enrolled participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2021-03-10 08:09:35 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER">
<DESCRIPTION>
<P>All or nearly all enrolled participants were included in safety analyses (low risk of bias). <BR/>86% of enrolled participants were included in efficacy analyses (unclear risk of bias). Reasons for missing data were lost to follow-up (n = 37), withdrew consent (30), moved from study area (17), received another rotavirus vaccine (2). Missing data were balanced between trial arms.  </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2021-03-17 08:01:31 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Kulkarni-2017_x002d_IND">
<DESCRIPTION>
<P>No exclusions from safety outcomes and ITT analyses (low risk of bias). Less that 15% of the participants were included for reactogenicity outcomes (high risk of bias).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2021-03-14 12:59:31 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDa">
<DESCRIPTION>
<P>Number of participants that were analysed was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2021-03-14 13:00:36 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDb">
<DESCRIPTION>
<P>10% (3/30) of partcipants in the intervention group were not analysed; reasons for missing data were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2021-03-14 13:09:59 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDc">
<DESCRIPTION>
<P>All randomised participants were analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_AF">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_GHA">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_KEN">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_MLI">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Ciarlet-2009_x002d_EU">
<DESCRIPTION>
<P>Quote: "In both treatment groups (RotaTeq + Hexavalent and Placebo + Hexavalent), ~84% of the infants reported 1 or more adverse events within 14 days after vaccination. One subject discontinued in the concomitant-use group because of abdominal pain (considered non-serious)" (Merck 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2003_x002d_USA">
<DESCRIPTION>
<P>Insufficient reporting of attrition/exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2004_x002d_USA">
<DESCRIPTION>
<P>Insufficient reporting of attrition/exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Dhingra-2014_x002d_IND">
<DESCRIPTION>
<P>Outcome data presented for all 100 participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Iwata-2013_x002d_JPN">
<DESCRIPTION>
<P>Attrition/exclusions balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-TEQ-Kim-2008_x002d_KOR">
<DESCRIPTION>
<P>Reason related to outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:13 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Lawrence-2012_x002d_CHN">
<DESCRIPTION>
<P>Attrition balanced across groups with reasons reported for withdrawal</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Levin-2017_x002d_AF">
<DESCRIPTION>
<P>Low attrition; reasons provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA">
<DESCRIPTION>
<P>Insufficient reporting of attrition/exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Mo-2017_x002d_CHN">
<DESCRIPTION>
<P>Low attrition and reasons provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Vesikari-2006a_x002d_FIN">
<DESCRIPTION>
<P>Insufficient reporting of attrition/exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006b_x002d_INT">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_AS">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_BGD">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_VNM">
<DESCRIPTION>
<P>Missing data balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2006_x002d_IND">
<DESCRIPTION>
<P>Low attrition; reasons for loss to follow-up were reported and evenly spread across groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-VAC-Bhandari-2009_x002d_IND">
<DESCRIPTION>
<P>Intussusception data reported for all enrolled participants; immunogenicity and reactogenicity were not reported for all participants and the reason was not clear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2014_x002d_IND">
<DESCRIPTION>
<P>&lt; 1% loss to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Chandola-2017_x002d_IND">
<DESCRIPTION>
<P>Intention-to-treat population was analysed for safety outcomes. Less than 5% loss to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2021-10-20 03:02:41 +0100" MODIFIED_BY="4773" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX_x00a0_Anh-2011_x002d_PHL">
<DESCRIPTION>
<P>All prepublished outcomes included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Anh-2011_x002d_VNM">
<DESCRIPTION>
<P>One outcome (rotavirus diarrhoea) not included in the prepublished protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1998_x002d_USA">
<DESCRIPTION>
<P>Not reported </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA">
<DESCRIPTION>
<P>All expected outcomes included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD">
<DESCRIPTION>
<P>All relevant outcomes appeared to be reported, protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Dennehy-2005_x002d_NA">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN">
<DESCRIPTION>
<P>All planned outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA">
<DESCRIPTION>
<P>All planned outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR">
<DESCRIPTION>
<P>All planned outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL">
<DESCRIPTION>
<P>All planned outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kawamura-2011_x002d_JPN">
<DESCRIPTION>
<P>Protocol published a priori, all prepublished outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Kerdpanich-2010_x002d_THA">
<DESCRIPTION>
<P>All prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kim-2012_x002d_KOR">
<DESCRIPTION>
<P>No indication of selective reporting bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013a_x002d_CHN">
<DESCRIPTION>
<P>Planned outcomes fully reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013b_x002d_CHN">
<DESCRIPTION>
<P>Planned outcomes fully reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2014_x002d_CHN">
<DESCRIPTION>
<P>Planned outcomes fully reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_AF">
<DESCRIPTION>
<P>All expected outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI">
<DESCRIPTION>
<P>All expected outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF">
<DESCRIPTION>
<P>All expected outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Narang-2009_x002d_IND">
<DESCRIPTION>
<P>All planned outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-NCT00158756_x002d_RUS">
<DESCRIPTION>
<P>All outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Omenaca-2012_x002d_EU">
<DESCRIPTION>
<P>All expected outcomes included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Phua-2005_x002d_SGP">
<DESCRIPTION>
<P>Reasons for low number of rotavirus gastroenteritis; "A smaller number of rotavirus-related gastroenteritis cases than expected were documented during the study. For 41% (160/387) of the reported gastroenteritis episodes, stool samples were not available for determination of the etiology of the gastroenteritis. No results were available for 6% (24/387) of the gastroenteritis episodes because of an insufficient quantity of stool samples collected or because of invalid results".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Phua-2009_x002d_AS">
<DESCRIPTION>
<P>All expected outcomes included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Rivera-2011_x002d_DOM">
<DESCRIPTION>
<P>Trial report did not provide enough details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-17 08:41:26 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="NO" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU">
<DESCRIPTION>
<P>The trial reported only on severe episodes of rotavirus diarrhoea and all-cause diarrhoea, and not on diarrhoea of any severity, which is unusual in these trials.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA">
<DESCRIPTION>
<P>Not all prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2008_x002d_ZAF">
<DESCRIPTION>
<P>All prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010a_x002d_ZAF">
<DESCRIPTION>
<P>All prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF">
<DESCRIPTION>
<P>All prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA">
<DESCRIPTION>
<P>All planned outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004a_x002d_FIN">
<DESCRIPTION>
<P>All planned outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN">
<DESCRIPTION>
<P>All prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU">
<DESCRIPTION>
<P>Data were provided only for rotavirus gastroenteritis and for severe gastroenteritis, not for all gastroenteritis episodes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2011_x002d_FIN">
<DESCRIPTION>
<P>All pre-published outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Ward-2006_x002d_USA">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Zaman-2009_x002d_BGD">
<DESCRIPTION>
<P>All planned outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:14 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="NO" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD">
<DESCRIPTION>
<P>Online registration of trial (NCT00737503) indicates all-cause diarrhoea as an outcome but results were not reported for this outcome in the study report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 08:09:53 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER">
<DESCRIPTION>
<P>All outcomes listed in the online trial record (NCT02145000) were fully reported in the publication.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 08:18:06 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Kulkarni-2017_x002d_IND">
<DESCRIPTION>
<P>All outcomes listed in the online trial record (NCT02133690) were fully reported in the publication.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 12:59:38 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDa">
<DESCRIPTION>
<P>Solicited adverse events listed as primary outcome in the trial registry (CTRI/2009/091/000821) were not fully reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:00:45 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDb">
<DESCRIPTION>
<P>All outcomes listed in the online trial record (CTRI/2009/091/000821) were fully reported in the publication.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:10:49 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDc">
<DESCRIPTION>
<P>All outcomes listed in the online trial record (CTRI/2010/091/003064) were fully reported in the publication.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_AF">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_GHA">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_KEN">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_MLI">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA">
<DESCRIPTION>
<P>Key expected outcome (episodes of gastroenteritis) not included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-TEQ-Ciarlet-2009_x002d_EU">
<DESCRIPTION>
<P>Not all prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-TEQ-Clark-2003_x002d_USA">
<DESCRIPTION>
<P>Not all prespecified outcomes reported. Poor reporting of efficacy data.<BR/>Quote: "Because there were relatively few confirmed cases of RV [rotavirus] caused by serotypes G1 and G2, the evidence is insufficient to declare that the efficacy of any buffered formulation is &gt; 0.0%".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-TEQ-Clark-2004_x002d_USA">
<DESCRIPTION>
<P>&#8805; 1 outcome of interest reported incompletely<BR/>Quote: "Only wild-type (i.e. non-vaccine-related) rotavirus cases were considered for the primary case definition".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Dhingra-2014_x002d_IND">
<DESCRIPTION>
<P>No indication of selective outcome reporting</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Iwata-2013_x002d_JPN">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-TEQ-Kim-2008_x002d_KOR">
<DESCRIPTION>
<P>Key expected outcome not included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Lawrence-2012_x002d_CHN">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Levin-2017_x002d_AF">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Mo-2017_x002d_CHN">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="NO" STUDY_ID="STD-TEQ-Vesikari-2006a_x002d_FIN">
<DESCRIPTION>
<P>&#8805; 1 outcome of interest reported incompletely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Vesikari-2006b_x002d_INT">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_AS">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_BGD">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_VNM">
<DESCRIPTION>
<P>Prespecified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2006_x002d_IND">
<DESCRIPTION>
<P>No indication of selective reporting; all outcomes in the trial register reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2009_x002d_IND">
<DESCRIPTION>
<P>No indication of selective outcome reporting</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2014_x002d_IND">
<DESCRIPTION>
<P>No indication of selective reporting; all outcomes in the trial register reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Chandola-2017_x002d_IND">
<DESCRIPTION>
<P>No indication of selective reporting; all outcomes in the trial register reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX_x00a0_Anh-2011_x002d_PHL">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Anh-2011_x002d_VNM">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1998_x002d_USA">
<DESCRIPTION>
<P>Trial report did not provide enough details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD">
<DESCRIPTION>
<P>No other bias apparent</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Dennehy-2005_x002d_NA">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-GSK_x005b_021_x005d_-2007_x002d_PAN">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-GSK_x005b_033_x005d_-2007_x002d_LA">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-GSK_x005b_041_x005d_-2007_x002d_KOR">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-GSK_x005b_101555_x005d_-2008_x002d_PHL">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kawamura-2011_x002d_JPN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kerdpanich-2010_x002d_THA">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Kim-2012_x002d_KOR">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013a_x002d_CHN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2013b_x002d_CHN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Li-2014_x002d_CHN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_AF">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Narang-2009_x002d_IND">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-NCT00158756_x002d_RUS">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Omenaca-2012_x002d_EU">
<DESCRIPTION>
<P>No apparent other bias<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:15 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Phua-2005_x002d_SGP">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Phua-2009_x002d_AS">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Rivera-2011_x002d_DOM">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA">
<DESCRIPTION>
<P>GlaxoSmithKline final report stated that part of the population received 3 doses of rotavirus vaccine. This was not mentioned on the original published report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Steele-2008_x002d_ZAF">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010a_x002d_ZAF">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Vesikari-2004a_x002d_FIN">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-RIX-Vesikari-2011_x002d_FIN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Ward-2006_x002d_USA">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Zaman-2009_x002d_BGD">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD">
<DESCRIPTION>
<P>Cluster-randomized trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 08:09:54 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Isanaka_x00a0_2017_x002d_NER">
<DESCRIPTION>
<P>No other sources of bias were detected.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-10 08:18:11 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="YES" STUDY_ID="STD-SIIL-Kulkarni-2017_x002d_IND">
<DESCRIPTION>
<P>No other sources of bias were detected.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 12:59:45 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDa">
<DESCRIPTION>
<P>Absence of other sources of bias could not be confirmed due to the very brief report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:00:51 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDb">
<DESCRIPTION>
<P>Absence of other sources of bias could not be confirmed due to the very brief report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-14 13:10:55 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-SIIL-Zade-2014_x002d_INDc">
<DESCRIPTION>
<P>Absence of other sources of bias could not be confirmed due to the very brief report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_AF">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_GHA">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_KEN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Armah-2010_x002d_MLI">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Block-2007_x002d_EU_x002f_USA">
<DESCRIPTION>
<P>Relevant information needed for assessment not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Ciarlet-2009_x002d_EU">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-03-17 08:51:19 +0000" MODIFIED_BY="59249928586857976988110908155847" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2003_x002d_USA">
<DESCRIPTION>
<P>Not enough detail to make a judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Clark-2004_x002d_USA">
<DESCRIPTION>
<P>Not enough detail to make a judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Dhingra-2014_x002d_IND">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Iwata-2013_x002d_JPN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Kim-2008_x002d_KOR">
<DESCRIPTION>
<P>Information not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Lawrence-2012_x002d_CHN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Levin-2017_x002d_AF">
<DESCRIPTION>
<P>Nine infants were unblinded after their first or second dose when rotavirus vaccine became available at their site. The 4 infants found to be on RotaTeq continued to receive their remaining study doses. Of the 5 infants on placebo, 2 were given the 2 recommended doses of Rotarix, but 3 were too old to receive Rotarix.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Merck_x005b_009_x005d_-2005_x002d_USA">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-TEQ-Mo-2017_x002d_CHN">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Vesikari-2006a_x002d_FIN">
<DESCRIPTION>
<P>Insufficient information to assess</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="UNKNOWN" STUDY_ID="STD-TEQ-Vesikari-2006b_x002d_INT">
<DESCRIPTION>
<P>Difficult to judge, as some important information about randomization/allocation concealment were not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_AS">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_BGD">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" RESULT="YES" STUDY_ID="STD-TEQ-Zaman-2010_x002d_VNM">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2006_x002d_IND">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2009_x002d_IND">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Bhandari-2014_x002d_IND">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2019-03-19 15:10:16 +0000" MODIFIED_BY="19988051606560128665111114094226" RESULT="YES" STUDY_ID="STD-VAC-Chandola-2017_x002d_IND">
<DESCRIPTION>
<P>No apparent other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-01-18 23:31:18 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2022-04-25 22:08:50 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2022-04-25 22:08:42 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Rotarix versus placebo</NAME>
<DICH_OUTCOME CHI2="42.98033863036984" CI_END="0.34750940266328795" CI_START="0.15648057869520032" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="OR" EFFECT_SIZE="0.2331919218814723" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="439" I2="72.08025720039159" I2_Q="87.98359575123679" ID="CMP-001.01" LOG_CI_END="-0.45903344008239655" LOG_CI_START="-0.8055395564491918" LOG_EFFECT_SIZE="-0.6322864982657942" METHOD="IV" MODIFIED="2022-04-25 15:40:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.2753405267139648E-5" P_Q="2.4312085627120616E-4" P_Z="8.497435006809036E-13" Q="16.643914091071373" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3258582752990239" TOTALS="YES" TOTAL_1="31503" TOTAL_2="25095" WEIGHT="99.99999999999999" Z="7.152882480146943">
<NAME>Rotavirus diarrhoea: severe (up to 1 year follow-up)</NAME>
<GROUP_LABEL_1>Rotarix</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Rotarix</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.4979447200087863" CI_END="0.1521964684175708" CI_START="0.028695240797842258" DF="3" EFFECT_SIZE="0.06608565888166198" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="89" I2="14.235351323892148" ID="CMP-001.01.01" LOG_CI_END="-0.8175954248621335" LOG_CI_START="-1.5421901264934172" LOG_EFFECT_SIZE="-1.1798927756777753" MODIFIED="2022-04-22 09:03:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.32102890789234895" P_Z="1.7364139925344258E-10" STUDIES="4" TAU2="0.11823656410939641" TOTAL_1="8188" TOTAL_2="6788" WEIGHT="16.37591840543773" Z="6.38300926225706">
<NAME>Low-mortality countries</NAME>
<DICH_DATA CI_END="0.9743826871936696" CI_START="0.043319739312137916" EFFECT_SIZE="0.20545073375262055" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.01127044117574479" LOG_CI_START="-1.3633141655194931" LOG_EFFECT_SIZE="-0.687292303347619" MODIFIED="2022-04-22 09:03:55 +0100" MODIFIED_BY="[Empty name]" ORDER="641" O_E="0.0" SE="0.7941971764038922" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA" TOTAL_1="108" TOTAL_2="107" VAR="0.6307491550079151" WEIGHT="4.330751496496533"/>
<DICH_DATA CI_END="0.8372185455906361" CI_START="0.011173918856424186" EFFECT_SIZE="0.09672131147540984" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="-0.07716115998161954" LOG_CI_START="-1.9517944867556263" LOG_EFFECT_SIZE="-1.014477823368623" MODIFIED="2021-03-15 07:05:22 +0000" MODIFIED_BY="59249928586857976988110908155847" ORDER="3" O_E="0.0" SE="1.1011688957316783" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN" TOTAL_1="245" TOTAL_2="123" VAR="1.212572936926924" WEIGHT="2.69289197166459"/>
<DICH_DATA CI_END="0.1006510026408811" CI_START="0.016151425433962065" EFFECT_SIZE="0.0403194390338917" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="60" LOG_CI_END="-0.9971818945037604" LOG_CI_START="-1.7917891432532531" LOG_EFFECT_SIZE="-1.3944855188785068" MODIFIED="2012-10-17 11:53:39 +0100" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8" ORDER="640" O_E="0.0" SE="0.4667562312847699" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU" TOTAL_1="2572" TOTAL_2="1302" VAR="0.2178613794431616" WEIGHT="7.619421192941563"/>
<DICH_DATA CI_END="0.5370003056370944" CI_START="0.0019216044915292471" EFFECT_SIZE="0.03212323457039808" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2700254671189438" LOG_CI_START="-2.7163359948266357" LOG_EFFECT_SIZE="-1.4931807309727898" MODIFIED="2022-04-22 09:03:46 +0100" MODIFIED_BY="[Empty name]" ORDER="581" O_E="0.0" SE="1.4369749134079088" STUDY_ID="STD-RIX-Phua-2009_x002d_AS" TOTAL_1="5263" TOTAL_2="5256" VAR="2.0648969017636674" WEIGHT="1.7328537443350454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5063361756917985" CI_END="0.28042214650215647" CI_START="0.15343839451446967" DF="3" EFFECT_SIZE="0.20743076904257066" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="185" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="-0.5521876906915689" LOG_CI_START="-0.8140659543415191" LOG_EFFECT_SIZE="-0.683126822516544" MODIFIED="2021-05-13 21:17:33 +0100" MODIFIED_BY="59249928586857976988110908155847" NO="2" P_CHI2="0.9174972495060452" P_Z="1.5260904488553845E-24" STUDIES="4" TAU2="0.0" TOTAL_1="17472" TOTAL_2="14199" WEIGHT="37.70814210190941" Z="10.225392137129866">
<NAME>Medium-mortality countries</NAME>
<DICH_DATA CI_END="0.36498362277466756" CI_START="0.13594279499244308" EFFECT_SIZE="0.22274849899933288" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="40" LOG_CI_END="-0.43772662238780524" LOG_CI_START="-0.8666438052000122" LOG_EFFECT_SIZE="-0.6521852137939087" MODIFIED="2021-05-13 21:17:04 +0100" MODIFIED_BY="59249928586857976988110908155847" ORDER="637" O_E="0.0" SE="0.25194807635818733" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA" TOTAL_1="1527" TOTAL_2="517" VAR="0.063477833180591" WEIGHT="10.640752219308709">
<FOOTNOTE>Multinational study: mainly medium-mortality countries (n=2) but also one high-mortality country: Venezuela.</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.31026203142408837" CI_START="0.11299836043683378" EFFECT_SIZE="0.1872407563986094" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="94" LOG_CI_END="-0.5082713683150408" LOG_CI_START="-0.9469278579183644" LOG_EFFECT_SIZE="-0.7275996131167026" MODIFIED="2021-05-13 21:16:53 +0100" MODIFIED_BY="59249928586857976988110908155847" ORDER="639" O_E="0.0" SE="0.2576689933776355" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU" TOTAL_1="10159" TOTAL_2="10010" VAR="0.06639331014824396" WEIGHT="10.561663009309665">
<FOOTNOTE>Multinational study: mainly medium-mortality countries (n=7) but also 4 high-mortality countries: Dominican Republic, Honduras, Nicaragua, Venezuela.</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.4342975139943898" CI_START="0.07650728490243099" EFFECT_SIZE="0.1822825379337974" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.36221265661890967" LOG_CI_START="-1.1162972100451207" LOG_EFFECT_SIZE="-0.7392549333320152" MODIFIED="2021-05-13 21:17:33 +0100" MODIFIED_BY="59249928586857976988110908155847" ORDER="636" O_E="0.0" SE="0.4429529994612973" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA" TOTAL_1="4211" TOTAL_2="2099" VAR="0.19620735973176004" WEIGHT="7.935456353332265">
<FOOTNOTE>Multinational study: mainly medium-mortality countries (n=4) but also two high-mortality countries: Dominican Republic and Honduras.</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.5352091944997744" CI_START="0.11293374659304856" EFFECT_SIZE="0.24585194639438418" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="32" LOG_CI_END="-0.2714764343168098" LOG_CI_START="-0.9471762638394565" LOG_EFFECT_SIZE="-0.6093263490781332" MODIFIED="2021-01-25 19:48:04 +0000" MODIFIED_BY="59249928586857976988110908155847" ORDER="1278" O_E="0.0" SE="0.39690942462970263" STUDY_ID="STD-RIX-Li-2014_x002d_CHN" TOTAL_1="1575" TOTAL_2="1573" VAR="0.1575370913598816" WEIGHT="8.57027051995877"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.156089704458495" CI_END="0.5932087642767588" CI_START="0.27075585987097045" DF="4" EFFECT_SIZE="0.40076769961506337" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="165" I2="50.95689055732902" ID="CMP-001.01.03" LOG_CI_END="-0.22679244117548894" LOG_CI_START="-0.5674221353228169" LOG_EFFECT_SIZE="-0.3971072882491529" MODIFIED="2022-04-13 12:21:44 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.08602496509283553" P_Z="4.880367892890923E-6" STUDIES="5" TAU2="0.09598919685319993" TOTAL_1="5843" TOTAL_2="4108" WEIGHT="45.915939492652846" Z="4.569865730085593">
<NAME>High-mortality countries</NAME>
<DICH_DATA CI_END="0.8005849433148042" CI_START="0.35435981461027133" EFFECT_SIZE="0.5326303897571079" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="47" LOG_CI_END="-0.09659258197608737" LOG_CI_START="-0.45055553419622896" LOG_EFFECT_SIZE="-0.27357405808615815" MODIFIED="2021-05-13 22:24:41 +0100" MODIFIED_BY="59249928586857976988110908155847" ORDER="631" O_E="0.0" SE="0.20791959027898288" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI" TOTAL_1="1182" TOTAL_2="591" VAR="0.043230556021780116" WEIGHT="11.224476897705477">
<FOOTNOTE>2 or 3 doses</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.3885558925562937" CI_START="0.11852740733583983" EFFECT_SIZE="0.2146031746031746" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="36" LOG_CI_END="-0.4105465004593688" LOG_CI_START="-0.9261812152365604" LOG_EFFECT_SIZE="-0.6683638578479646" MODIFIED="2021-05-13 22:24:46 +0100" MODIFIED_BY="59249928586857976988110908155847" ORDER="632" O_E="0.0" SE="0.3028863838931256" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF" TOTAL_1="2116" TOTAL_2="1050" VAR="0.09174016154785386" WEIGHT="9.920604807916327">
<FOOTNOTE>2 or 3 doses</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.7654923235244409" CI_START="0.09728689850976907" EFFECT_SIZE="0.4144385026737968" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.24686583356254063" LOG_CI_START="-1.011945641622918" LOG_EFFECT_SIZE="-0.38253990403018867" MODIFIED="2021-05-13 22:24:56 +0100" MODIFIED_BY="59249928586857976988110908155847" ORDER="638" O_E="0.0" SE="0.7394320917412364" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF" TOTAL_1="379" TOTAL_2="96" VAR="0.5467598182968202" WEIGHT="4.747585559783548">
<FOOTNOTE>2 or 3 doses</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.6237521601613032" CI_START="0.17699337794314698" EFFECT_SIZE="0.33226495726495725" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="39" LOG_CI_END="-0.20498793732925985" LOG_CI_START="-0.7520429820932756" LOG_EFFECT_SIZE="-0.47851545971126774" MODIFIED="2019-03-19 15:09:44 +0000" MODIFIED_BY="19988051606560128665111114094226" ORDER="1279" O_E="0.0" SE="0.3213428412605279" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD" TOTAL_1="350" TOTAL_2="350" VAR="0.10326122162938883" WEIGHT="9.654255026898953"/>
<DICH_DATA CI_END="0.9863509525652584" CI_START="0.34035111972083987" EFFECT_SIZE="0.5794011142061282" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="40" LOG_CI_END="-0.005968531667657409" LOG_CI_START="-0.46807281627201064" LOG_EFFECT_SIZE="-0.23702067396983398" MODIFIED="2021-07-06 16:07:27 +0100" MODIFIED_BY="19988051606560128665111114094226" ORDER="37048" O_E="0.0" SE="0.27144234422969743" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD" TOTAL_1="1816" TOTAL_2="2021" VAR="0.07368094624091356" WEIGHT="10.369017200348543">
<FOOTNOTE>Adjusted for clustering: design effect of 2.53, villages randomised to Rotarix versus no intervention, true sample size: n=10,108</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="42.98033863036983" CI_END="0.3385786437167968" CI_START="0.23253865947494992" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="OR" EFFECT_SIZE="0.2805933426451002" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="439" I2="72.08025720039157" I2_Q="0.0" ID="CMP-001.36" LOG_CI_END="-0.47034043904591577" LOG_CI_START="-0.633504835458181" LOG_EFFECT_SIZE="-0.5519226372520484" METHOD="IV" MODIFIED="2022-04-25 15:39:14 +0100" MODIFIED_BY="[Empty name]" NO="36" P_CHI2="2.2753405268916005E-5" P_Q="1.0" P_Z="3.969313788184725E-40" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="31503" TOTAL_2="25095" WEIGHT="100.00000000000001" Z="13.25961441408015">
<NAME>Rotavirus diarrhoea: severe (up to 1 year follow-up)</NAME>
<GROUP_LABEL_1>Rotarix</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Rotarix</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9743826871936696" CI_START="0.043319739312137916" EFFECT_SIZE="0.20545073375262055" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.01127044117574479" LOG_CI_START="-1.3633141655194931" LOG_EFFECT_SIZE="-0.687292303347619" MODIFIED="2022-04-21 10:25:07 +0100" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.7941971764038922" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA" TOTAL_1="108" TOTAL_2="107" VAR="0.6307491550079151" WEIGHT="1.456361951332854"/>
<DICH_DATA CI_END="0.8372185455906361" CI_START="0.011173918856424186" EFFECT_SIZE="0.09672131147540984" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="-0.07716115998161954" LOG_CI_START="-1.9517944867556263" LOG_EFFECT_SIZE="-1.014477823368623" MODIFIED="2022-04-21 10:25:07 +0100" MODIFIED_BY="[Empty name]" ORDER="581" O_E="0.0" SE="1.1011688957316783" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN" TOTAL_1="245" TOTAL_2="123" VAR="1.212572936926924" WEIGHT="0.7575619100628465"/>
<DICH_DATA CI_END="0.36498362277466756" CI_START="0.13594279499244308" EFFECT_SIZE="0.22274849899933288" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="40" LOG_CI_END="-0.43772662238780524" LOG_CI_START="-0.8666438052000122" LOG_EFFECT_SIZE="-0.6521852137939087" MODIFIED="2022-04-21 10:25:06 +0100" MODIFIED_BY="[Empty name]" ORDER="631" O_E="0.0" SE="0.25194807635818733" STUDY_ID="STD-RIX-Salinas-2005_x002d_LA" TOTAL_1="1527" TOTAL_2="517" VAR="0.063477833180591" WEIGHT="14.471178743223817">
<FOOTNOTE>Multinational study: mainly medium-mortality countries (n=2) but also one high-mortality country: Venezuela.</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.31026203142408837" CI_START="0.11299836043683378" EFFECT_SIZE="0.1872407563986094" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="94" LOG_CI_END="-0.5082713683150408" LOG_CI_START="-0.9469278579183644" LOG_EFFECT_SIZE="-0.7275996131167026" MODIFIED="2022-04-21 10:25:05 +0100" MODIFIED_BY="[Empty name]" ORDER="632" O_E="0.0" SE="0.2576689933776355" STUDY_ID="STD-RIX-Ruiz_x002d_Palac-06_x002d_LA_x002f_EU" TOTAL_1="10159" TOTAL_2="10010" VAR="0.06639331014824396" WEIGHT="13.83571730552091">
<FOOTNOTE>Multinational study: mainly medium-mortality countries (n=7) but also 4 high-mortality countries: Dominican Republic, Honduras, Nicaragua, Venezuela.</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.1006510026408811" CI_START="0.016151425433962065" EFFECT_SIZE="0.0403194390338917" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="60" LOG_CI_END="-0.9971818945037604" LOG_CI_START="-1.7917891432532531" LOG_EFFECT_SIZE="-1.3944855188785068" MODIFIED="2022-04-21 10:25:12 +0100" MODIFIED_BY="[Empty name]" ORDER="636" O_E="0.0" SE="0.4667562312847699" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU" TOTAL_1="2572" TOTAL_2="1302" VAR="0.2178613794431616" WEIGHT="4.2164383266862195"/>
<DICH_DATA CI_END="0.5370003056370944" CI_START="0.0019216044915292471" EFFECT_SIZE="0.03212323457039808" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2700254671189438" LOG_CI_START="-2.7163359948266357" LOG_EFFECT_SIZE="-1.4931807309727898" MODIFIED="2022-04-21 10:25:12 +0100" MODIFIED_BY="[Empty name]" ORDER="637" O_E="0.0" SE="1.4369749134079088" STUDY_ID="STD-RIX-Phua-2009_x002d_AS" TOTAL_1="5263" TOTAL_2="5256" VAR="2.0648969017636674" WEIGHT="0.4448643752645874"/>
<DICH_DATA CI_END="0.8005849433148042" CI_START="0.35435981461027133" EFFECT_SIZE="0.5326303897571079" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="47" LOG_CI_END="-0.09659258197608737" LOG_CI_START="-0.45055553419622896" LOG_EFFECT_SIZE="-0.27357405808615815" MODIFIED="2022-04-21 10:25:12 +0100" MODIFIED_BY="[Empty name]" ORDER="638" O_E="0.0" SE="0.20791959027898288" STUDY_ID="STD-RIX-Madhi-2010_x002d_MWI" TOTAL_1="1182" TOTAL_2="591" VAR="0.043230556021780116" WEIGHT="21.248837737041224">
<FOOTNOTE>2 or 3 doses</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.3885558925562937" CI_START="0.11852740733583983" EFFECT_SIZE="0.2146031746031746" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="36" LOG_CI_END="-0.4105465004593688" LOG_CI_START="-0.9261812152365604" LOG_EFFECT_SIZE="-0.6683638578479646" MODIFIED="2022-04-21 10:25:12 +0100" MODIFIED_BY="[Empty name]" ORDER="639" O_E="0.0" SE="0.3028863838931256" STUDY_ID="STD-RIX-Madhi-2010_x002d_ZAF" TOTAL_1="2116" TOTAL_2="1050" VAR="0.09174016154785386" WEIGHT="10.013052677149611">
<FOOTNOTE>2 or 3 doses</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.7654923235244409" CI_START="0.09728689850976907" EFFECT_SIZE="0.4144385026737968" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.24686583356254063" LOG_CI_START="-1.011945641622918" LOG_EFFECT_SIZE="-0.38253990403018867" MODIFIED="2022-04-21 10:25:11 +0100" MODIFIED_BY="[Empty name]" ORDER="641" O_E="0.0" SE="0.7394320917412364" STUDY_ID="STD-RIX-Steele-2010b_x002d_ZAF" TOTAL_1="379" TOTAL_2="96" VAR="0.5467598182968202" WEIGHT="1.680077868652365">
<FOOTNOTE>2 or 3 doses</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.4342975139943898" CI_START="0.07650728490243099" EFFECT_SIZE="0.1822825379337974" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.36221265661890967" LOG_CI_START="-1.1162972100451207" LOG_EFFECT_SIZE="-0.7392549333320152" MODIFIED="2022-04-21 10:25:11 +0100" MODIFIED_BY="[Empty name]" ORDER="640" O_E="0.0" SE="0.4429529994612973" STUDY_ID="STD-RIX-Tregnaghi-2011_x002d_LA" TOTAL_1="4211" TOTAL_2="2099" VAR="0.19620735973176004" WEIGHT="4.681776827559963">
<FOOTNOTE>Multinational study: mainly medium-mortality countries (n=4) but also two high-mortality countries: Dominican Republic and Honduras.</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.5352091944997744" CI_START="0.11293374659304856" EFFECT_SIZE="0.24585194639438418" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="32" LOG_CI_END="-0.2714764343168098" LOG_CI_START="-0.9471762638394565" LOG_EFFECT_SIZE="-0.6093263490781332" MODIFIED="2022-04-13 12:23:06 +0100" MODIFIED_BY="[Empty name]" ORDER="1278" O_E="0.0" SE="0.39690942462970263" STUDY_ID="STD-RIX-Li-2014_x002d_CHN" TOTAL_1="1575" TOTAL_2="1573" VAR="0.1575370913598816" WEIGHT="5.831001843815979"/>
<DICH_DATA CI_END="0.6237521601613032" CI_START="0.17699337794314698" EFFECT_SIZE="0.33226495726495725" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="39" LOG_CI_END="-0.20498793732925985" LOG_CI_START="-0.7520429820932756" LOG_EFFECT_SIZE="-0.47851545971126774" MODIFIED="2022-04-13 12:23:06 +0100" MODIFIED_BY="[Empty name]" ORDER="1279" O_E="0.0" SE="0.3213428412605279" STUDY_ID="STD-RIX-Colgate-2016_x002d_BGD" TOTAL_1="350" TOTAL_2="350" VAR="0.10326122162938883" WEIGHT="8.895876454820446"/>
<DICH_DATA CI_END="0.9863509525652584" CI_START="0.34035111972083987" EFFECT_SIZE="0.5794011142061282" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="40" LOG_CI_END="-0.005968531667657409" LOG_CI_START="-0.46807281627201064" LOG_EFFECT_SIZE="-0.23702067396983398" MODIFIED="2022-04-13 12:23:06 +0100" MODIFIED_BY="[Empty name]" ORDER="37048" O_E="0.0" SE="0.27144234422969743" STUDY_ID="STD-RIX-Zaman-2017_x002d_BGD" TOTAL_1="1816" TOTAL_2="2021" VAR="0.07368094624091356" WEIGHT="12.467253978869183">
<FOOTNOTE>Adjusted for clustering: design effect of 2.53, villages randomised to Rotarix versus no intervention, true sample size: n=10,108</FOOTNOTE>
</DICH_DATA>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.4979447200087863" CI_END="0.12645630183469117" CI_START="0.03017631042762609" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="0.06177365635684214" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="89" I2="14.235351323892148" I2_Q="0.0" ID="CMP-001.37" LOG_CI_END="-0.8980595231101115" LOG_CI_START="-1.520333861276024" LOG_EFFECT_SIZE="-1.2091966921930677" METHOD="IV" MODIFIED="2022-04-25 22:08:08 +0100" MODIFIED_BY="[Empty name]" NO="37" P_CHI2="0.32102890789234895" P_Q="1.0" P_Z="2.5931544763510563E-14" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8188" TOTAL_2="6788" WEIGHT="99.99999999999999" Z="7.617161182987709">
<NAME>Rotavirus diarrhoea: severe (up to 1 year follow-up)</NAME>
<GROUP_LABEL_1>Rotarix</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Rotarix</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9743826871936696" CI_START="0.043319739312137916" EFFECT_SIZE="0.20545073375262055" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.01127044117574479" LOG_CI_START="-1.3633141655194931" LOG_EFFECT_SIZE="-0.687292303347619" MODIFIED="2022-04-25 22:07:25 +0100" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.7941971764038922" STUDY_ID="STD-RIX-Bernstein-1999_x002d_USA" TOTAL_1="108" TOTAL_2="107" VAR="0.6307491550079151" WEIGHT="21.182748494385205"/>
<DICH_DATA CI_END="0.8372185455906361" CI_START="0.011173918856424186" EFFECT_SIZE="0.09672131147540984" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="-0.07716115998161954" LOG_CI_START="-1.9517944867556263" LOG_EFFECT_SIZE="-1.014477823368623" MODIFIED="2022-04-25 22:07:25 +0100" MODIFIED_BY="[Empty name]" ORDER="581" O_E="0.0" SE="1.1011688957316783" STUDY_ID="STD-RIX-Vesikari-2004b_x002d_FIN" TOTAL_1="245" TOTAL_2="123" VAR="1.212572936926924" WEIGHT="11.018719209947086"/>
<DICH_DATA CI_END="0.1006510026408811" CI_START="0.016151425433962065" EFFECT_SIZE="0.0403194390338917" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="60" LOG_CI_END="-0.9971818945037604" LOG_CI_START="-1.7917891432532531" LOG_EFFECT_SIZE="-1.3944855188785068" MODIFIED="2022-04-25 22:07:25 +0100" MODIFIED_BY="[Empty name]" ORDER="636" O_E="0.0" SE="0.4667562312847699" STUDY_ID="STD-RIX-Vesikari-2007a_x002d_EU" TOTAL_1="2572" TOTAL_2="1302" VAR="0.2178613794431616" WEIGHT="61.3279909809092"/>
<DICH_DATA CI_END="0.5370003056370944" CI_START="0.0019216044915292471" EFFECT_SIZE="0.03212323457039808" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2700254671189438" LOG_CI_START="-2.7163359948266357" LOG_EFFECT_SIZE="-1.4931807309727898" MODIFIED="2022-04-25 22:07:25 +0100" MODIFIED_BY="[Empty name]" ORDER="637" O_E="0.0" SE="1.4369749134079088" STUDY_ID="STD-RIX-Phua-2009_x002d_AS" TOTAL_1="5263" TOTAL_2="5256" VAR="2.0648969017636674" WEIGHT="6.470541314758509"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>
